Regina LaBelle

Regina LaBelle

politician United States

Regina LaBelle is a public policy expert and former acting director of the White House Office of National Drug Control Policy under the Biden administration. She has extensive experience in drug policy and has emphasized the importance of relying on accurate threat assessments when formulating strategies to combat drug trafficking. In recent discussions, LaBelle highlighted the significant role of Mexican cartels in the fentanyl crisis, contrasting the Trump administration's focus on Canada as a source of fentanyl. Her insights call into question the rigor and basis of drug policies and emergency declarations related to border security.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
64,039
Power
547$
Sentiment
6.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Turkey 1 6.00 0.08% +0% 84,339,067 64,039 $720,000 547$
Totals 1 84,339,067 64,039 $720,000 547$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Turkey Turkey: Regina LaBelle expressed that the decree would not effectively address homelessness and that more resources should be allocated for untreated mental health issues. 6

Hürriyet: Trump evsizleri hapsetmeye karar verdi: Akıl hastalığı olan bireyler ve madde bağımlıları zorla sokaklardan toplanacak

United States United States: Regina LaBelle is the director of the Addiction and Public Policy Initiative at Georgetown University. 7

CNN: Despite pledge to expand naloxone access, Trump administration proposal would cut overdose prevention programs

Canada Canada: Regina LaBelle, the former acting director of the White House Office of National Drug Control Policy under the Joe Biden administration, said in an interview that the U.S. Drug Enforcement Administration’s most recent threat assessment didn’t even mention Canada. 6

The Globe and Mail: New fentanyl data undercuts White House’s portrayal of Canada’s role in U.S. drug crisis